Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Suven Pharmaceuticals June-Quarter Consol Net Profit 607.7 Mln Rupees

Aug 9 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * SUVEN PHARMACEUTICALS LTD JUNE-QUARTER CONSOL NET PROFIT
607.7
MILLION RUPEES
    * SUVEN PHARMACEUTICALS LTD JUNE-QUARTER CONSOL REVENUE FROM
OPERATIONS 2.31 BILLION RUPEES

Source text for Eikon:  ID: 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cohance Lifesciences

See all news